96 related articles for article (PubMed ID: 1661303)
21. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
Okano M
Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855
[TBL] [Abstract][Full Text] [Related]
22. [Fluctuation in Epstein-Barr virus-related antibody titers by age: response differences between the IgG antibodies to VCA and anti-EBNA antibodies].
Kumagai E; Tanaka R; Kumagai T; Katsuki T; Sawada S
Rinsho Byori; 1984 Jun; 32(6):666-70. PubMed ID: 6092744
[No Abstract] [Full Text] [Related]
23. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
[TBL] [Abstract][Full Text] [Related]
24. T-cell control of herpesvirus infections: lessons from the Epstein-Barr virus.
Rickinson AB
Prog Brain Res; 1983; 59():189-202. PubMed ID: 6320264
[No Abstract] [Full Text] [Related]
25. [The relationship between Epstein-Barr virus and rheumatoid arthritis].
Xu WD; Shi GY; Cai XH
Zhonghua Nei Ke Za Zhi; 1985 Aug; 24(8):457-9, 509. PubMed ID: 2996850
[No Abstract] [Full Text] [Related]
26. Polyclonal immunoglobulin secretion by human B lymphocytes exposed to Epstein-Barr virus in vitro.
Kirchner H; Tosato G; Blaese RM; Broder S; Magrath IT
J Immunol; 1979 Apr; 122(4):1310-3. PubMed ID: 221572
[No Abstract] [Full Text] [Related]
27. [Humoral response to Epstein-Barr virus of patients with nasopharyngeal cancer and its use in the differential diagnosis of the disease].
Gurtsevich VE; Plakhov IV; Chuĭkina NA; Abdulin NA
Vestn Akad Med Nauk SSSR; 1984; (5):29-34. PubMed ID: 6331022
[No Abstract] [Full Text] [Related]
28. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
Yarchoan R; Redfield RR; Broder S
J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
[TBL] [Abstract][Full Text] [Related]
30. Role of Vicia villosa-adherent CD8+ T cells in the immune response to Epstein-Barr virus.
Kundu SK; Menezes J
Viral Immunol; 1991; 4(1):23-32. PubMed ID: 1648359
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus in the development of multiple sclerosis.
Ascherio A
Expert Rev Neurother; 2008 Mar; 8(3):331-3. PubMed ID: 18345964
[No Abstract] [Full Text] [Related]
32. [Clinico-pathological analysis of anti-early antigen (EA)-IgG antibodies in Epstein-Barr virus infection].
Nakamura Y; Iwasawa A; Aoki Y; Shimada S; Fujita K; Niwa A; Yoshida K
Rinsho Byori; 1989 May; 37(5):566-72. PubMed ID: 2549287
[No Abstract] [Full Text] [Related]
33. Epstein-barr virus: environmental trigger of multiple sclerosis?
Lünemann JD; Kamradt T; Martin R; Münz C
J Virol; 2007 Jul; 81(13):6777-84. PubMed ID: 17459939
[No Abstract] [Full Text] [Related]
34. Monoclonal antibody to the Epstein-Barr virus receptor induces human B lymphocyte activation and differentiation.
Nemerow GR; McNaughton ME; Cooper NR
Trans Assoc Am Physicians; 1985; 98():290-300. PubMed ID: 3022444
[No Abstract] [Full Text] [Related]
35. [Rhinopharyngeal carcinoma and Epstein-Barr virus: study of a sample of Italian patients].
Caliceti U; Cevenini R; Donati M
Acta Otorhinolaryngol Ital; 1985; 5(1):83-90. PubMed ID: 2994355
[No Abstract] [Full Text] [Related]
36. [Persistent polyclonal B-cell lymphocytosis].
Troussard ; Mossafa H; Flandrin G
Ann Biol Clin (Paris); 2002; 60(3):273-80. PubMed ID: 12050042
[TBL] [Abstract][Full Text] [Related]
37. Studies of the Epstein-Barr herpesvirus relationship with Hodgkin's disease and the use of virus immunological markers in differential diagnostics of nasopharyngeal carcinoma.
Mazurenko NP; Gurtsevich VE; Stepina VN; Plakhov IV
Arch Geschwulstforsch; 1983; 53(3):253-9. PubMed ID: 6311138
[No Abstract] [Full Text] [Related]
38. Studies on the significance of Epstein-Barr virus-specific IgM in human sera.
Edwards JM; McSwiggan DA
IARC Sci Publ (1971); 1975; (11 Pt 2):59-62. PubMed ID: 191384
[No Abstract] [Full Text] [Related]
39. Evaluation of delayed hypersensitivity reactions to lymphoid cell lines and antibodies to Epstein-Barr virus.
Levine PH; Ho JH; Nkrumah F; Andrese AP
IARC Sci Publ (1971); 1978; (24 Pt 2):893-8. PubMed ID: 221411
[No Abstract] [Full Text] [Related]
40. Epstein-Barr virus-related serology in nasopharyngeal carcinoma and controls.
Henle W; Henle G; Ho JH
IARC Sci Publ (1971); 1978; (20):427-37. PubMed ID: 215525
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
